相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Modeling Parkinson's Disease
C. Warren Olanow et al.
ANNALS OF NEUROLOGY (2009)
Overexpression of Glycogen Synthase Kinase 3β Sensitizes Neuronal Cells to Ethanol Toxicity
Ying Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3 beta, beta-Catenin, and Neurotrophin Cascades
Akihiko Wada
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
Agnes Petit-Paitel et al.
PLOS ONE (2009)
Drug Selection and Timing of Initiation of Treatment in Early Parkinson's Disease
Anthony H. V. Schapira et al.
ANNALS OF NEUROLOGY (2008)
GSK3β and endoplasmic reticulum stress mediate rotenone-induced death of SK-N-MC neuroblastoma cells
Yuan-Yuan Chen et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS
John Dill et al.
JOURNAL OF NEUROSCIENCE (2008)
Lithium delays progression of amyotrophic lateral sclerosis
Francesco Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lithium: Bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium
Frederic Marmol
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sovan Sarkar et al.
HUMAN MOLECULAR GENETICS (2008)
Activation of double-stranded RNA-activated protein kinase by mild impairment of oxidative metabolism in neurons
Xin Wang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
The 6-hydroxydopamine model of Parkinson's disease
Nicola Simola et al.
NEUROTOXICITY RESEARCH (2007)
Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesions
L Truong et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium:: involvements of Bcl-2 and Bax
MBH Youdim et al.
NEUROPHARMACOLOGY (2004)
Glycogen synthase kinase 3: a drug target for CNS therapies
RV Bhat et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation
XD Chen et al.
FASEB JOURNAL (2004)
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
RS Jope
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Reversal of thiamine deficiency-induced neurodegeneration
ZJ Ke et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease
H Wei et al.
NEUROSCIENCE (2001)
β-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment
HF Wei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)